Ken Griffin West Pharmaceutical Services Inc Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$277.16 - $333.3 $2.11 Million - $2.53 Million	7,600 Added 20.6%	44,500 $13.4 Million
Q2 2024 Aug 14, 2024	SELL	$314.68 - $395.94 $67.2 Million - $84.6 Million	-213,700 Reduced 85.28%	36,900 $12.2 Million
Q1 2024 May 15, 2024	BUY	$338.27 - $413.0 $70.8 Million - $86.5 Million	209,400 Added 508.25%	250,600 $99.2 Million
Q4 2023 Feb 14, 2024	BUY	$318.29 - $392.21 $4.97 Million - $6.12 Million	15,600 Added 60.94%	41,200 $14.5 Million
Q3 2023 Nov 14, 2023	BUY	$354.9 - $412.41 $5.54 Million - $6.43 Million	15,600 Added 156.0%	25,600 $9.61 Million
Q2 2023 Aug 14, 2023	BUY	$334.63 - $382.47 $1.94 Million - $2.22 Million	5,800 Added 138.1%	10,000 $3.82 Million
Q1 2023 May 15, 2023	SELL	$232.5 - $346.47 $1.26 Million - $1.87 Million	-5,400 Reduced 56.25%	4,200 $1.46 Million
Q4 2022 Feb 14, 2023	BUY	$209.34 - $261.61 $523,350 - $654,025	2,500 Added 35.21%	9,600 $2.26 Million
Q3 2022 Nov 14, 2022	SELL	$246.08 - $343.65 $492,160 - $687,300	-2,000 Reduced 21.98%	7,100 $1.75 Million

801

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23.8B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.